The University of Chicago Header Logo

Connection

Jon E. Grant to Narcotic Antagonists

This is a "connection" page, showing publications Jon E. Grant has written about Narcotic Antagonists.
Connection Strength

5.188
  1. Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder. J Clin Psychopharmacol. 2021 Sep-Oct 01; 41(5):611-612.
    View in: PubMed
    Score: 0.721
  2. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014 Feb; 34(1):134-8.
    View in: PubMed
    Score: 0.426
  3. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010 Oct; 197(4):330-1.
    View in: PubMed
    Score: 0.338
  4. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry. 2009 Apr 01; 65(7):600-6.
    View in: PubMed
    Score: 0.302
  5. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl). 2008 Nov; 200(4):521-7.
    View in: PubMed
    Score: 0.289
  6. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008 May; 69(5):783-9.
    View in: PubMed
    Score: 0.286
  7. Medication management of pathological gambling. Minn Med. 2006 Sep; 89(9):44-8.
    View in: PubMed
    Score: 0.255
  8. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
    View in: PubMed
    Score: 0.245
  9. Understanding and treating kleptomania: new models and new treatments. Isr J Psychiatry Relat Sci. 2006; 43(2):81-7.
    View in: PubMed
    Score: 0.244
  10. Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosom Med. 2004 Mar-Apr; 66(2):198-206.
    View in: PubMed
    Score: 0.214
  11. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry. 2004 Jan-Mar; 16(1):27-34.
    View in: PubMed
    Score: 0.212
  12. An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002 Apr; 63(4):349-56.
    View in: PubMed
    Score: 0.188
  13. Adolescent kleptomania treated with naltrexone--a case report. Eur Child Adolesc Psychiatry. 2002 Apr; 11(2):92-5.
    View in: PubMed
    Score: 0.188
  14. A case of kleptomania and compulsive sexual behavior treated with naltrexone. Ann Clin Psychiatry. 2001 Dec; 13(4):229-31.
    View in: PubMed
    Score: 0.183
  15. The psychopharmacology of pathological gambling. Semin Clin Neuropsychiatry. 2001 Jul; 6(3):184-94.
    View in: PubMed
    Score: 0.178
  16. Cold pressor pain and gambling disorder: implications for the opioid system. CNS Spectr. 2020 06; 25(3):426-433.
    View in: PubMed
    Score: 0.154
  17. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9.
    View in: PubMed
    Score: 0.112
  18. Compulsive buying treated with motivational interviewing and imaginal desensitization. Ann Clin Psychiatry. 2011 Aug; 23(3):226-7.
    View in: PubMed
    Score: 0.090
  19. Augmentation with naltrexone to treat compulsive sexual behavior: a case series. Ann Clin Psychiatry. 2010 Feb; 22(1):56-62.
    View in: PubMed
    Score: 0.081
  20. Pharmacological treatment of adolescent pathological gambling. Int J Adolesc Med Health. 2010 Jan-Mar; 22(1):129-38.
    View in: PubMed
    Score: 0.080
  21. Naltrexone effect on physiological and subjective response to a cold pressor task. Biol Psychol. 2008 Feb; 77(2):233-6.
    View in: PubMed
    Score: 0.069
  22. [Kleptomania: clinical characteristics and treatment]. Braz J Psychiatry. 2008 May; 30 Suppl 1:S11-5.
    View in: PubMed
    Score: 0.068
  23. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry. 2007 Mar-Apr; 15(2):80-5.
    View in: PubMed
    Score: 0.066
  24. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin Neuropharmacol. 2006 Mar-Apr; 29(2):77-9.
    View in: PubMed
    Score: 0.062
  25. Advances in the pharmacological treatment of pathological gambling. J Gambl Stud. 2003; 19(1):85-109.
    View in: PubMed
    Score: 0.049
  26. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001 Jun 01; 49(11):914-21.
    View in: PubMed
    Score: 0.044
  27. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res. 2009 Mar 31; 166(1):76-84.
    View in: PubMed
    Score: 0.019
  28. Pathological gambling. Current status and new treatments. Minn Med. 2002 Jul; 85(7):48-50, 52.
    View in: PubMed
    Score: 0.012
  29. A preliminary report on possible naltrexone and nonsteroidal analgesic interactions. J Clin Psychopharmacol. 2001 Dec; 21(6):632-4.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.